title: Minimal residual disease following autologous stem cell transplant in myeloma: impact on outcome is independent of induction regimen.
authors.affiliation: St James's Institute of Oncology, Leeds, UK.
authors.forename: Ruth M
authors.initials: RM
authors.lastname: de Tute
authors.affiliation: St James's Institute of Oncology, Leeds, UK.
authors.forename: Andy C
authors.initials: AC
authors.lastname: Rawstron
authors.affiliation: Clinical Trials Research Unit, University of Leeds, UK.
authors.forename: Walter M
authors.initials: WM
authors.lastname: Gregory
authors.affiliation: Clinical Trials Research Unit, University of Leeds, UK.
authors.forename: J Anthony
authors.initials: JA
authors.lastname: Child
authors.affiliation: Institute of Cancer Research, London, UK University of Arkansas for Medical Sciences, Little Rock, AR, USA.
authors.forename: Faith E
authors.initials: FE
authors.lastname: Davies
authors.affiliation: Clinical Trials Research Unit, University of Leeds, UK.
authors.forename: Sue E
authors.initials: SE
authors.lastname: Bell
authors.affiliation: St James's Institute of Oncology, Leeds, UK.
authors.forename: Gordon
authors.initials: G
authors.lastname: Cook
authors.affiliation: Clinical Trials Research Unit, University of Leeds, UK.
authors.forename: Alexander J
authors.initials: AJ
authors.lastname: Szubert
authors.affiliation: University of Birmingham, UK.
authors.forename: Mark T
authors.initials: MT
authors.lastname: Drayson
authors.affiliation: University of Newcastle, UK.
authors.forename: Graham H
authors.initials: GH
authors.lastname: Jackson
authors.affiliation: Institute of Cancer Research, London, UK University of Arkansas for Medical Sciences, Little Rock, AR, USA.
authors.forename: Gareth J
authors.initials: GJ
authors.lastname: Morgan
authors.affiliation: St James's Institute of Oncology, Leeds, UK rogerowen@nhs.net.
authors.forename: Roger G
authors.initials: RG
authors.lastname: Owen
mesh_terms: D015703:Antigens, CD / Q000235:genetics / Q000378:metabolism; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D015870:Gene Expression; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D060828:Induction Chemotherapy / Q000379:methods*; D009101:Multiple Myeloma / Q000175:diagnosis* / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D018365:Neoplasm, Residual; D011379:Prognosis; D012074:Remission Induction; D016019:Survival Analysis; D014182:Transplantation, Autologous; D016896:Treatment Outcome
chemical_list: D015703:Antigens, CD
keywords: flow cytometry; induction; minimal residual disease; myeloma